The scam, which involved GLP-1s such as Wegovy and Ozempic, is representative of the growing number of GLP-1 weight loss ruses, likely leaving some consumers wondering how they can protect themselves
Some examples of these mislabeled imports included: 5-azacytidine, a chemotherapy drug used to treat leukemia since the 1970s (Shipment IDs: 799-7374291-0/12/1, 799-9734889-2/13/1, 799-9753233-9/13/1, 799-0004861-4/10003/1) Rapamycin, an immunosuppressant commonly prescribed for organ transplant patients (Shipment ID: 336-5726740-3/62/1) Fenofibrate, a cholesterol medication (Shipment ID: 799-9084120-8/33/1) Zonalta, a psychiatric medicine for bipolar disorder
Cohort 25 adult participants Trial design Randomised crossover design Markers GLP-1, glucose, insulin & appetite Published in Journal of Obesity Weight Loss Therapy Supports healthier post-meal glucose balance ~8% Lower glucose rise at 60 mins ~9.7% Reduction at 90 mins Lower Post-meal glucose excursions observed overall A sharper spike vs
While Saxenda is specifically approved for chronic weight management, Ozempic is often discussed due to its weight loss side effects in patients with type 2 diabetes
Most of the patients who desperately seek fair complexion or a new treatment modality for their refractory facial melanosis are typically internet and social media savvy
We actually see patients who come in on these agents, who may or may not have been engaged in a lifestyle intervention